(415) 476-3831 (appts)
(415) 502-4372 (fax)

Box 0106, UCSF; San Francisco, CA 94143-0106

additional websites:

UCSF Physician Referral Directory

University of California, Berkeley, B.A., 1985, Neurobiology
University of Vermont, Burlington, M.D., 1991, Medicine

Goldsby RE, Saulys AJ, Helton JG. Pediatric pulmonary artery thromboembolism: an illustrative case. Pediatr Emergency Care 12:105-107, 1996.

Goldsby RE, Pappin A, Pycher T, Scott S, Adams R. Histologic response of osteosarcoma to neoadjuvant chemotherapy with and without ifosfamide. Internatl J Pediatr Hematol Oncol 4:143-149, 1997.

Goldsby RE, Feusner J. Lymphoblast morphology in predicting meningeal relapse with low chamber counts and lymphoblasts. Med Pediatr Oncol 29:98-102, 1997.

Goldsby RE, Singh M, Preston BD. Mouse DNA polymerase epsilon gene (Pole) maps to Chromosome 5. Mammalian Genome 9:91-92, 1998.

Goldsby RE, Singh M, Preston BD. Mouse DNA polymerase delta gene (Pold1) maps to Chromosome 7. Mammalian Genome 9:92-92, 1998.

Goldsby RE, Bruggers CS, Brothman AR, Sorenson PHB, Beckwith JB, Pysher TJ. Spindle cell sarcoma of the kidney with ganglionic elements (malignant ectomesenchymoma) associated with chromosomal abnormalities. J Pediatr Hematol Oncol 20:160-164, 1998.

Goldsby RE and Carroll WL. Molecular biology of pediatric lymphomas. J Pediatr Hematol Oncol 20:282-296, 1998.

Goldsby RE, Perkins SL, Virshup DM, Brothman AR, Bruggers CS. Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia. J Pediatr Hematol Oncol 21:240-243,1999.

Goldsby RE, Lawrence NA, Hays L, Olmsted E, Xin C, Singh M, Preston BD. Defective DNA polymerase delta proofreading causes cancer susceptibility in mice. Nat Med 7:638-639, 2001.

Goldsby RE, Lawrence NA, Hays L, Olmsted E, Xin C, Slayton W, Spangrude GJ, Singh M, Preston BD. High incidence of epithelial tumors in mice with defective polymerase proofreading. Proc Natl Acad Sci U S A. 99:15560-5, 2002.

Goldsby RE, Pulsipher M, Adams R, Coffin C, Albritton K, WagnerL. Pleural effusions in 3 pediatric patients treated with STI-571. J Pediatr Hematol Oncol. 24:694-5, 2002.

Holly Z, Randall RL, Brothman AR, Maxwell T, Coffin CM, Goldsby RE. HER-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification. J Pediatr Hematol Oncol 25:27-32, 2003.

Meeker N D, Goldsby R, Terrill K, Delaney K, Slayton W. Dapsone therapy for pediatric patients with autoimmune thrombocytopenic purpura. J Pediatr Hematol Oncol 25:173-5,2003.

Holt D, Brown J, Terrill K, Goldsby R, Meyers R, Heximer J, Nordfors B, Slayton W. Response to intravenous immunoglobin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatr 111:87-90, 2003.

Longacre A, Sun T, Goldsby RE, Preston BD, Storb U. Ig gene somatic hypermutation in mice defective for DNA polymerase delta proofreading. Internatl Immunol 15:477-481, 2003

Terrill KR, Lemons RS, Goldsby RE. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer. J Pediatr Hematol Oncol. 25:864-7, 2003

Wagner LM, Crews KR, Iacono LC, Houghton PJ, Fuller CE, McCarville MB, Goldsby RE, Albritton K Stewart CF, Santana VM. Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors. Clin Cancer Res. 10(3):840-848, 2004

Goldsby RE and Matthay KK. Neuroblastoma, evolving therapies for a disease with many faces. Pediatr Drugs 6(2):107-22, 2004.

Goldsby RE and Ablin AR. Surviving childhood cancer; now what? Controversies regarding long-term follow-up. Pediatr Blood Cancer 43:14, 2004.

Iemsawatdikul K, Gooding CA, Twomey EL, Kim GE, Goldsby RE, Cohen I, O'Donnell RJ. Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma. Pediatr Radiol. 35(7):717-21, 2005.

Kim GE, Beach B, Gastier-Foster JM, Murata-Collins JL, Rowland JM, O'Donnell RJ, Goldsby RE. Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia. Pediatr Blood Cancer 45(1):57-9, 2005.

Sanchez R, Etzell J, Kim G, Packman S, Fairley C, Goldsby R. Pediatric malignancies. Case 2. Peripheral T-cell lymphoma in an adolescent with unsuspected Gaucher disease. J Clin Oncol. 23(21):4792-3, 2005.

Goldsby RE, Taggert D, Ablin AR. Surviving Childhood Cancer: The Impact on Life. Pediatr Drugs 8:71-84, 2006.

Crompton BD, Goldsby RE, Weinberg VK, Feren R, O'Donnell RJ, Ablin AR. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatr Blood Cancer 47(3):255-9, 2006.

Weisstein JS, Goldsby RE, O'Donnell RJ. Oncologic approaches to pediatric limb preservation. J Am Acad Orthop Surg. 13(8):544-54, 2005.

Wagner LM, McAllister N, Goldsby RE, Rausen AR, McNall-Knapp RY, McCarville MB, Albritton K. Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatr Blood Cancer 48(2):132-9, 2007.

Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK. Malignant pheochromocytomas and paragangliomas: A phase 2 study f therapy with high dose 131-I metaidobenzylguanidine. Ann NY Acad Sci 1073:465-90, 2006.

2/1/07